FDA Waits For NDI Notifications Increase On Tail Of 'No Objection' Uptick

FDA has seen an uptick in “acknowledgement with no objection” response letters to dietary supplement firms' s NDI notifications, but says those positive responses still account for only a quarter of all its responses.

FDA entrance sign 2016

FDA is optimistic that an increase in “no objection” responses to new dietary ingredient notifications signals a positive trend, but has a more critical view of the industry's clarity about when the notifications are required and information they should contain.

More from United States

More from North America